BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 25481458)

  • 21. Molecular insight of isotypes specific β-tubulin interaction of tubulin heterodimer with noscapinoids.
    Santoshi S; Naik PK
    J Comput Aided Mol Des; 2014 Jul; 28(7):751-63. PubMed ID: 24916062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).
    Naik PK; Lopus M; Aneja R; Vangapandu SN; Joshi HC
    J Comput Aided Mol Des; 2012 Feb; 26(2):233-47. PubMed ID: 22170255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tubulin binding, protein-bound conformation in solution, and antimitotic cellular profiling of noscapine and its derivatives.
    Bennani YL; Gu W; Canales A; Díaz FJ; Eustace BK; Hoover RR; Jiménez-Barbero J; Nezami A; Wang T
    J Med Chem; 2012 Mar; 55(5):1920-5. PubMed ID: 22320354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new antiproliferative noscapine analogue: chemical synthesis and biological evaluation.
    Ghaly PE; Abou El-Magd RM; Churchill CD; Tuszynski JA; West FG
    Oncotarget; 2016 Jun; 7(26):40518-40530. PubMed ID: 27777381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
    Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
    Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidation of the Tubulin-targeted Mechanism of Action of 9-(3-pyridyl) Noscapine.
    Pradhan S; Mahaddalkar T; Choudhary S; Manhcukonda N; Nagireddy PR; Kantevari S; Lopus M
    Curr Top Med Chem; 2017; 17(22):2569-2574. PubMed ID: 28056737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comprehension into Target Binding and Spatial Fingerprints of Noscapinoid Analogues as Inhibitors of Tubulin.
    Mandavi S; Verma SK; Banjare L; Dubey A; Bhatt R; Thareja S; Jain AK
    Med Chem; 2021; 17(6):611-622. PubMed ID: 31951171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 9-Ethynyl noscapine induces G2/M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer.
    Nagireddy PKR; Kumar D; Kommalapati VK; Pedapati RK; Kojja V; Tangutur AD; Kantevari S
    Drug Dev Res; 2022 May; 83(3):605-614. PubMed ID: 34612529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,3-Benzodioxole-Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin-Bound Structure.
    Yong C; Devine SM; Abel AC; Tomlins SD; Muthiah D; Gao X; Callaghan R; Steinmetz MO; Prota AE; Capuano B; Scammells PJ
    ChemMedChem; 2021 Sep; 16(18):2882-2894. PubMed ID: 34159741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents.
    Mishra RC; Gundala SR; Karna P; Lopus M; Gupta KK; Nagaraju M; Hamelberg D; Tandon V; Panda D; Reid MD; Aneja R
    Bioorg Med Chem Lett; 2015; 25(10):2133-40. PubMed ID: 25891106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical characterization and molecular dynamic simulation of β-sitosterol as a tubulin-binding anticancer agent.
    Mahaddalkar T; Suri C; Naik PK; Lopus M
    Eur J Pharmacol; 2015 Aug; 760():154-62. PubMed ID: 25912799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational design of the microtubule-targeting anti-breast cancer drug EM015.
    Aneja R; Lopus M; Zhou J; Vangapandu SN; Ghaleb A; Yao J; Nettles JH; Zhou B; Gupta M; Panda D; Chandra R; Joshi HC
    Cancer Res; 2006 Apr; 66(7):3782-91. PubMed ID: 16585205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Class of N-Sulfonyl and N-Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer Cells.
    Yong C; Devine SM; Gao X; Yan A; Callaghan R; Capuano B; Scammells PJ
    ChemMedChem; 2019 Dec; 14(23):1968-1981. PubMed ID: 31714012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of docetaxel and newly synthesized 9-Br-trimethoxybenzyl-noscapine improve tubulin binding and enhances antitumor activity in breast cancer cells.
    Dash SG; Kantevari S; Guru SK; Naik PK
    Comput Biol Med; 2021 Dec; 139():104996. PubMed ID: 34753081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of noscapine analogues as microtubule-interfering agents.
    Dai HL; Zheng JB; Lin M; Zheng J; Zhou FS; Dong XC; Guo L; Liu JW; Wen R
    Yao Xue Xue Bao; 2012 Oct; 47(10):1347-57. PubMed ID: 23289148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel 9'-substituted-noscapines: synthesis with Suzuki cross-coupling, structure elucidation and biological evaluation.
    Porcù E; Sipos A; Basso G; Hamel E; Bai R; Stempfer V; Udvardy A; Bényei AC; Schmidhammer H; Antus S; Viola G
    Eur J Med Chem; 2014 Sep; 84():476-90. PubMed ID: 25050880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents.
    Debono AJ; Mistry SJ; Xie J; Muthiah D; Phillips J; Ventura S; Callaghan R; Pouton CW; Capuano B; Scammells PJ
    ChemMedChem; 2014 Feb; 9(2):399-410. PubMed ID: 24339417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.
    Mishra RC; Karna P; Gundala SR; Pannu V; Stanton RA; Gupta KK; Robinson MH; Lopus M; Wilson L; Henary M; Aneja R
    Biochem Pharmacol; 2011 Jul; 82(2):110-21. PubMed ID: 21501599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of 9-(
    Pragyandipta P; Naik MR; Bastia B; Naik PK
    3 Biotech; 2023 Feb; 13(2):38. PubMed ID: 36636578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.